非酒精性脂肪性肝炎患者肠道菌群的变化及意义

杨林辉; 蔡俊; 陈东风

非酒精性脂肪性肝炎患者肠道菌群的变化及意义

1. 武警重庆总队医院消化内科
2. 武警重庆总队医院检验科
3. 第三军医大学大坪医院野战外科研究所消化内科

详细信息

中图分类号: R575.5
计量
- 文章访问数: 2818
- HTML全文浏览量: 23
- PDF下载量: 669
- 被引次数: 0
出版历程
- 出版日期: 2012-02-20

Alteration and significance of intestinal flora in patients with NASH

摘要

摘要: 目的探讨非酒精性脂肪性肝炎肠道菌群的变化及意义。方法选择肠道菌群中具有代表性的细菌共5种进行培养和计数。选择健康正常成人、单纯性非酒精性脂肪肝和非酒精性脂肪性肝炎(NASH)患者各30例,计数各组肠道菌群中5种细菌的数量,比较各组细菌数量的变化。结果 NASH组患者存在不同程度的肠道菌群失调,主要表现为厌氧菌减少(P<0.05),而需氧菌显著增多(P<0.05),而兼性厌氧菌酵母样真菌没有显著变化(P>0.05)。结论 NASH患者存在肠道菌群失调、革兰阴性杆菌过度生长的现象,提示肠道微生态失衡可能参与了NASH的发生发展。
- 肠道菌群 /
- 脂肪肝,非酒精性
Abstract: Objective To investigate alteration and significance of intestinal flora in patients with NASH.Methods Intestinal bacteria were routinely cultured and counted.Thirty health adults, thirty patients with nonalcoholic fatty liver and thirty patients with nonalcoholic steatohepatitis were selected and their intestinal bacteria were detected respectively.Results Alteration of intestinal flora included decrease in anaerobic bacteria (P<0.05) and increase in aerobic bacteria (P<0.05) in patients with NASH.There was no significant change in aerotolerant anaerobe such as toruloid fungi (P>0.05) .Conclusion There is alteration in intestinal flora and overgrowth of gram negative bacilli in patients with NASH.The results suggest that unbalance of intestinal microecology probably involve in the development of NASH.
- intestinal flora /
- fatty liver disease

HTML全文

参考文献(14)

[1]Sheth SG, Cordon FD, Chopra S.Nonacoholic steatohepati-tis[J].Ann Intern Med, 1997, 126 (2) :137-145.

[2]Vanni E, Bugianesi E.The gut-liver axis in nonalcoholic fat-ty liver disease:another pathway to insulin resistance[J].Hepatology, 2009, 49 (6) :1791-1793.

[3]中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志, 2010, 18 (3) :163-166.

[4]Hart AL, Stagg AJ, Frame M, et al.Review article:the roleof the gut flora in health and disease and its modification astherapy[J].Aliment Pharmacol Ther, 2002, 16 (8) :1383-1393.

[5]B ckhed F, Ding H, Wang T, et al.The gut microbiota as anenvironmental factor that regulates fat storage[J].Proc NatlAcad Sci USA, 2004, 101 (44) :15718-15723.

[6]Turnbaugb PJ, Ley RE, Mahowald MA, et al.An obesity-associated gut microbiome with increased capacity for energyharvest[J].Nature, 2006, 444 (7122) :1027-1030.

[7]Cani PD, Amar J, Iglesias MA, et al.Metabolic endotoxemiainitiates obesity and insulin resistance[J].Diabetes, 2007, 56 (7) :1761-1772.

[8]Wigg AJ, Roberts-Thomson IC, Dymock RB, et al.The role ofsmall intestinal bacterial overgrowth, intestinal permeability, en-dotoxaemia, and tumour necrosis factor alpha in the pathogene-sis of non-alcoholic steatohepatitis[J].Gut, 2001, 48 (20) :206-211.

[9]Han DW.Intestinal endotoxemia as a pathogenetic mecha-nism in liver failure[J].World J Gastroenterol, 2002, 8 (6) :961-965.

[10]Yee SB, Harkema JR, Ganey PE, et al.The coagulation sys-tem contributes to synergistic liver injury from exposure tomonocrotaline and bacterial lipopolysaccharide[J].ToxicolSci, 2003, 74 (2) :457-469.

[11]Hirose M, Nishikawa M, Qian W, et al.Mannose-conjuga-ted alendronate selectively depletes Kupffer cells and inhibitsendotoxemic shock in the mice[J].Hepatol Res, 2006, 36 (1) :3-10.

[12]Higuchi Y, Kawakami S, Yamashita F, et al.The potentialrole of fucosylated cationic liposome/NFkappaB decoy com-plexes in the treatment of cytokine-related liver disease[J].Biomaterials, 2007, 28 (26) :532-539.

[13]Day CP, James OF.Steatohepatitis:a tale of two“hits”[J].Gastroenterology, 1998, 114 (4) :842-845.

[14]范建高.调整肠道微生态平衡-脂肪性肝炎防治的新靶点[J].现代医药卫生, 2007, 23 (3) :317-318

施引文献

资源附件(0)

访问统计